Biotech 2050 Podcast

Robert Plenge, EVP & Chief Research Officer, BMS: Reinventing Drug Discovery

Nello Mainolfi, Founder, President & CEO, Kymera: Pioneering Targeted Protein Degradation

Nick Myerberg, Partner & Head of AI at Braidwell on AI's Next Era in Drug Discovery

Robert Jacks, CEO of Sparrow Pharmaceuticals | Precision Medicine, Biotech Strategy & Leadership

Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients

Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision

Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership

Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics

Adial Pharmaceuticals' CEO, Cary Claiborne, discusses the company's precision treatment approach to alcohol use disorder (AUD). Claiborne highlights the significant unmet need in AUD treatment, noting that existing treatments often require abstinence and have undesirable side effects. Adial's drug, a repurposed low-dos...

Sheila Gujrathi, MD on Leadership, Biotech Innovation & The Mirror Effect for Women Leaders

Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms

Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation

Brian Hilberdink on Boehringer’s U.S. Growth, AI & Pharma’s Next Frontier

Johan Luthman, Lundbeck EVP R&D, on Rebuilding Neuroscience Pipelines & Drug Discovery

Christophe Bourdon, LEO Pharma CEO, on Dermatology Innovation, Rare Disease & Scalable Growth

Matt Gline, Roivant Sciences CEO, on Clinical Breakthroughs, Capital Discipline & Building Biotech

Jay Hartenbach, President & COO, Diakonos Oncology on Reprogramming Cancer Immunity Breakthrough AI

John Lepore, CEO & President - ProFound Therapeutics, on Proteome, AI, & Bold First-in-Class Drugs

Jason Kelly - Ginkgo Bioworks CEO and Co-Founder on Automation, AI Data & Biotech’s Reset

Arun Swaminathan: Coya CEO on Neuroinflammation, BD Strategy & Patient-Driven Biotech

How Nimbus CEO Abbas Kazimi Builds Resilient Pipelines Through Culture, Rigor & Smart Bets